2022. 3. 4. Treatment types recommended for consideration in adjuvant or neoadjuvant early breast cancer included chemotherapy anti-HER2 therapy
UOB En
2022. 3. 4. Treatment types recommended for consideration in adjuvant or neoadjuvant early breast cancer included chemotherapy anti-HER2 therapy
2020. 1. 28. Neoadjuvant systemic therapy has a different aim. The efficacy of systemic therapies based on the sensitivities to drugs
hyz
2019. 2. 6. Neoadjuvant therapy has some particu- lar advantages that distinguish it from adjuvant treatment. First it reduces tumor size
The Oncologist Colomer theoncologist.
2020. 1. 28. Adjuvant and neoadjuvant therapy for breast cancer. Tadahiko Shien12
fulltext
Dual HER2 blockade in adjuvant and neoadjuvant treatment of HER2-positive breast cancer: the role of pertuzumab. ABSTRACT. Trastuzumab and pertuzumab belong
2015. 10. 28. for clinical trials in primary breast cancer based on neoadjuvant ... experimental therapy improves on the pCR rate of control. The.
.full text
neoadjuvant chemoendocrine therapy in primary breast cancer. A. Makris T. J. Powles